Top Growth Trends in the Budesonide Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theBudesonide Market?
The increasing prevalence of respiratory diseases is also expected to drive the growth of the budesonide market. Respiratory diseases refer to medical conditions that impact the organs and tissues involved in gas exchange in air-breathing animals. This rise in respiratory diseases is primarily due to growing air pollution, particularly exposure to particulate matter and allergens, which significantly affect asthma and chronic obstructive pulmonary disease (COPD). Budesonide is used to treat asthma and COPD, reducing inflammation, enhancing airflow, and alleviating symptoms such as wheezing and shortness of breath. In May 2024, the National Center for Health Statistics (NCHS) reported that the prevalence of current asthma among U.S. adults aged 18 and older increased from 8.4% in 2021 to 8.7% in 2022. Moreover, the number of asthma episodes in the past 12 months increased from 3.3% in 2021 to 3.7% in 2022. Thus, the rising prevalence of respiratory diseases is propelling the growth of the budesonide market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp
What is the Predicted Annual Growth Rate of theBudesonide Market Impact Industry Trends by 2034?
The budesonide market has shown strong growth, expected to rise from $9.72 billion in 2024 to $10.36 billion in 2025 at a CAGR of 6.6%. Growth in previous years was driven by the increasing prevalence of respiratory diseases, greater awareness of inhaled corticosteroids, the introduction of combination therapies, expansion of healthcare access, and the use of budesonide for off-label inflammatory bowel disease treatment.
The budesonide market is projected to experience solid growth, expanding to $13.25 billion by 2029 at a CAGR of 6.3%. Key factors driving this expansion include increasing demand for effective treatments, novel drug delivery systems, rising use of budesonide, an aging population prone to asthma, and the growing availability of generic budesonide products. Notable trends include the rising adoption of biologics and biosimilars, advancements in drug delivery technology, regulatory approvals for new formulations, continued innovations in drug administration, and broader technological developments in the pharmaceutical sector.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21121
Which Upcoming Market Trends and Innovations Are Set to Influence theBudesonide Market’s Path Forward?
In the budesonide market, companies are advancing oral therapy formulations to enhance patient convenience and adherence for respiratory conditions. For instance, in February 2024, Takeda Pharmaceuticals, a Japan-based company, received FDA approval for EOHILIA, an oral budesonide suspension. This is the first FDA-approved oral medication for eosinophilic esophagitis (EoE) in patients aged 11 and older, providing a convenient treatment option for managing this condition.
Who Are the Dominant Market Players Pushing the Boundaries of theBudesonide Market?
Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report
What Are the Core Segments of the Budesonide Market, and How Do They Contribute to Growth?
The budesonide market covered in this report is segmented –
1) By Type: Inhalation Powder, Aerosols, Injectable Suspension, Tablets And Capsules
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications
Subsegments:
1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)
2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers
3) By Injectable Suspension: Pre-filled Syringes, Vials
4) By Tablets And Capsules: Oral Tablets, Oral Capsules
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=21121&type=smp
What Regions Are Dominating the Budesonide Market Growth?
North America was the largest region in the budesonide market in 2024. The regions covered in the budesonide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Budesonide Market 2025, By The Business Research Company:
Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025
Vascular Embolization Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report
Inhalation And Nasal Spray Generic Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
